Oviva
Company

Last deal

$72.2M
Local Amount - EUR 80.M

Amount

Series C

Stage

31.08.2021

Date

6

all rounds

$105.2M

Total amount

General

About Company
Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Oviva Switzerland

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

London-based Oviva offers a behavior change platform that digitizes the treatment of type 2 diabetes and obesity. Through personalized behavior change programs, combining smartphone apps and learning portals, Oviva supports dietitian-led interventions for patients with conditions like type 2 diabetes and complex obesity. By eliminating the need for clinic appointments, Oviva helps patients achieve better health outcomes while saving healthcare systems significant costs by preventing complications. Founded in 2013, Oviva partners with health insurers, healthcare systems, and doctors to provide accessible care through tailored nutrition advice and personalized coaching via their phones.
Contacts

location

Website URL

Social url